4P-Pharma Appoints Didier Landais as CEO

Founded in 2014 by Revital Rattenbach, 4P-Pharma is entering a new phase of its development. During the latest strategic board meeting, Didier Landais was appointed as the new CEO of 4P-Pharma. Effective September 1st, 2023, Didier Landais succeeds Revital Rattenbach as CEO while she takes on the role of Executive Chairwoman.

Didier Landais brings over 30 years of international experience in the pharmaceutical and biotechnology industry to his new role. His career has been marked by achievements in research and development, strategy, and business development.

With his extensive international experience and proven leadership, Didier Landais is the ideal choice for this strategic role. His past accomplishments reflect his exceptional ability to guide teams toward excellence, translating ambitious visions into tangible results. Together, the new executive leadership team will work to accelerate the company’s development.

Didier Landais holds a Ph.D. in Molecular and Cellular Biology from the University Louis Pasteur (Strasbourg) and an Executive MBA from ESSEC (Paris). He began his career as a researcher and oncology project leader at the Gene Therapy Division of RPR-Gencell (Sanofi) before taking on roles such as Director of Business Development and General Manager of Cell Therapy at IDM Pharma. His leadership roles also included Director of Development at Biotecnol and Chief Business Officer at Genome Profiling. While serving as Global Head of Licensing at Servier, he concluded several significant agreements with companies such as Celsius, Oncodesign, and Seal Rock. More recently, he held positions as COO and CBO at Labgenius Ltd in London.

As CEO, Didier Landais assumes responsibility for the company’s overall strategy in science, partnerships, and external growth. Revital Rattenbach, now 4P-Pharma’s Executive Chairwoman, remains actively involved in financial consolidation and strategic directions, ensuring the continuity of the company’s founding vision.

4P-Pharma is a clinical-stage biotech company founded in Lille in 2014, pioneering drug regeneration. The company focuses on untreated serious diseases with high unmet medical needs.

Have you read?
The Best Marketplace To Buy And Sell Cranes Online.
Patientory’s Chrissa McFarlane Shares Vision To Transform Healthcare With Improved Data Access.
7 steps to build alignment between your board and executive team.
Why nobody cares about what most companies have to say or sell.
Beyond the Classroom: The Rising Importance of STEM for All Students.